|
|
Article: PharmaPrint Reports First Quarter Results; $5.41 Million in Revenues; Announces Plans to Consolidate Manufacturing Activities.
- Article from:
- Business Wire
- Article date:
- August 16, 1999
CopyrightCOPYRIGHT 1999 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
IRVINE, Calif.--(BUSINESS WIRE)--Aug. 16, 1999--
PharmaPrint Inc. (Nasdaq:PPRT), a leader in the development of dietary supplements, functional foods and pharmaceuticals from natural plant extracts, today reported revenues from manufacturing of $5.41 million for the first quarter ended June 30, 1999. The Company reported a net loss of $3.28 million, or $0.24 per share for the quarter, compared to a net loss of $4.43 million, or $0.32 per share, for the quarter ended June 30, 1998.
The Company also announced that it has signed several agreements with Lone Star Pharmaceuticals, Inc., a wholly-owned subsidiary of Adams Laboratories, Inc., a well-known ...